BRIEF-PledPharma says futility analysis in PLIANT study completed and approved by the DSMB

Mon Aug 18, 2014 2:37am EDT

Related Topics

Aug 18 (Reuters) - PledPharma publ AB : * Says futility analysis in PLIANT study completed and approved by the DSMB * Says analysis covers first 30 patients in study who have completed 4

treatment cycles with chemotherapy mixture FOLFOX * Source text for Eikon * Further company coverage

FILED UNDER: